METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ancient herb meets keto: new trial targets fatty liver
Disease control Not yet recruitingThis study tests whether a traditional Chinese medicine formula called Chazhu Xiaoli Formula (CXD), combined with a very low-carb (ketogenic) diet, can reduce liver fat in people with MASLD (fatty liver disease). 135 adults aged 18-50 will be randomly assigned to one of three gro…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE2 • Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Could a soy supplement help your liver? new trial investigates
Disease control Not yet recruitingThis phase 2 trial tests whether daidzein, a natural compound found in soy, can improve liver tissue health in adults with metabolic dysfunction-associated steatotic liver disease (MASLD). 44 participants scheduled for gallbladder surgery will take daidzein capsules or receive st…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug ACT500 targets dual liver disease in early trial
Disease control Not yet recruitingThis early-stage trial is testing a new drug called ACT500 in 24 people who have both fatty liver disease and chronic hepatitis B. The main goal is to check the drug's safety and how the body processes it at different doses. Participants will take ACT500 or a placebo daily, and r…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Morning or evening workout: which melts liver fat best?
Disease control Not yet recruitingThis study looks at whether exercising in the morning or evening makes a bigger difference in reducing liver fat for postmenopausal women with fatty liver disease. Sixty-three women will be placed into morning exercise, evening exercise, or a no-exercise group for 12 weeks. Resea…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Universidad de Almeria • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a bile acid pill in breast milk protect babies from liver problems?
Disease control Not yet recruitingThis study tests whether giving a bile acid pill (TUDCA) to breastfeeding mothers with fatty liver disease can make their breast milk healthier for their babies. Eighty mother-infant pairs will be randomly assigned to receive TUDCA or a placebo for a short time after birth. The g…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New pill for fatty liver enters early human testing
Disease control Not yet recruitingThis early-stage study tests a new oral drug called ACT500 in 24 adults with fatty liver disease (MASLD). The main goal is to check safety and how the drug moves through the body. Participants take one pill daily in different dose groups. The study does not aim to cure the diseas…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Blood tests may reveal fatty liver risks
Knowledge-focused Not yet recruitingThis study will check if certain blood-based inflammation markers are linked to fatty liver disease (MASLD) in 100 adults. Participants will have their blood tested and their liver health assessed. The goal is to better understand the role of inflammation in this condition, not t…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New MRI methods could spot liver damage earlier
Knowledge-focused Not yet recruitingThis study tests new MRI techniques to measure blood flow and tissue details in the liver. Researchers will scan 110 people, including healthy volunteers and those with chronic liver disease or fibrosis, to see if these scans can reliably detect liver damage. The goal is to devel…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
When you eat may matter as much as what you eat, new study suggests
Knowledge-focused Not yet recruitingThis study will compare meal timing habits between 400 participants, including new mothers and people with fatty liver disease, along with healthy controls. Participants will complete diet diaries and questionnaires, with some undergoing additional tests like blood sugar monitori…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Maria Chondronikola • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Fatty liver patients: could a blood test spot heart attack risk?
Knowledge-focused Not yet recruitingThis study will check if a routine blood measure called mean platelet volume (MPV) can predict acute coronary syndrome (heart attack or unstable angina) in people with metabolic dysfunction-associated steatotic liver disease (MASLD). Researchers will compare MPV levels between 60…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New ultrasound test could replace liver biopsies for fatty liver patients
Knowledge-focused Not yet recruitingThis study tests whether two different ultrasound machines can accurately measure liver stiffness and inflammation in people with fatty liver disease. About 95 to 100 adults will take part, including healthy liver donors and patients with fatty liver. The goal is to see if these …
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Fatty liver study to reveal obesity link
Knowledge-focused Not yet recruitingThis study looks at 200 adults with fatty liver disease to find out how many are also obese. It will also describe the health details of patients who have fatty liver but are not overweight. The goal is to better understand the different types of fatty liver disease.
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Virtual twins could unlock secrets of fatty liver and heart risk
Knowledge-focused Not yet recruitingThis study aims to create detailed computer models, or 'virtual twins,' of people with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). By analyzing data from over 7,700 adults, researchers hope to better understand how the disease progresses and predict who migh…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Scientists probe whether cutting insulin levels can curb liver fat
Knowledge-focused Not yet recruitingThis study looks at how lowering insulin levels changes the way the liver makes sugar and fat. Researchers will give 36 overweight or obese adults with insulin resistance and fatty liver disease two different insulin infusions—one that keeps insulin high and one that lowers it by…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Can ultrasound replace MRI for fatty liver diagnosis?
Knowledge-focused Not yet recruitingThis study will test whether a special ultrasound technique can measure liver stiffness and fat as accurately as MRI in people with fatty liver disease. Researchers will compare results from both imaging methods in 145 healthy volunteers and patients. The goal is to find a simple…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC